unmet challenges in high risk scientific board ... · simone ferrero 14.30-14.50 how i treat high...
TRANSCRIPT
Unmet challenges in high risk hematological malignancies: from benchside to clinical practiceTurin, September 13-14, 2018Torino Incontra Centro Congressi
Scientific Board: Marco Ladetto (Alessandria)Umberto Vitolo (Turin)
1
REQUESTED AUSPICES FACULTYSergio Amadori Rome - ItalyEmanuele Angelucci Genoa - ItalyHervè Avet Loiseau Toulouse - FranceRenato Bassan Mestre (VE) - ItalyMario Boccadoro Turin - ItalyFrancesc Bosch Barcelona - SpainChristian Buske Ulm - GermanyAngelo Michele Carella Genoa - ItalyRobert Chen Duarte - USAAnnalisa Chiappella Turin - ItalyPaolo Corradini Milan - ItalyFrancesco A. D’Amore Aarhu - DenmarkMatteo G. Della Porta Rozzano (MI) - ItalyBrunangelo Falini Perugia - ItalyFelicetto Ferrara Naples - ItalyAndres J.M. Ferreri Milan - ItalySimone Ferrero Turin - ItalyRobin Foà Rome - ItalyGianluca Gaidano Novara - ItalyOlivier Hermine Paris - FranceGeorg Hess Mainz - GermanyWolfgang Hiddemann Munich - GermanyMarco Ladetto Alessandria - ItalyAlessandra Larocca Turin - ItalyGeorg Lenz Munster - GermanyMaurizio Martelli Rome - Italy
Massimo Massaia Cuneo - ItalyGrzegorz Nowakowski Rochester - USAFabrizio Pane Naples - ItalyFrancesco Passamonti Varese - ItalyStefano A. Pileri Milan - ItalyPatrizia Pregno Turin - ItalyAlessandro Rambaldi Bergamo - ItalyGiovanna Rege Cambrin Orbassano (TO) - ItalyUmberto Ricardi Turin - ItalyGiuseppe Rossi Brescia - ItalyStephen Schuster Philadelphia - USAMichele Spina Aviano (PN) - ItalyHarald Stein Berlin - GermanyAyalew Tefferi Rochester - USAJan Trka Prague - Czech RepublicCarlo Visco Vicenza - ItalyUmberto Vitolo Turin - ItalyAlberto Zamò Turin - ItalyPier Luigi Zinzani Bologna - Italy
AZIENDA OSPEDALIERO-UNIVERSITARIA Città della Salute e della Scienza di Torino – Presidio Ospedaliero Le Molinette
FIL – Fondazione Italiana Linfomi
GITMO - Gruppo Italiano per il Trapianto di Midollo Osseo, cellule staminali emopoietiche e terapia cellulare
SIE – Società Italiana di Ematologia
SIES – Società Italiana di Ematologia Sperimentale
Rete Oncologica del Piemonte
Unmet challenges in high risk hematological malignancies:
from benchside to clinical practice
THURSDAY SEPTEMBER 13, 2018
2 3
10.30 Welcome and Introduction Marco Ladetto, Umberto Ricardi, Umberto Vitolo
11.00-11.30 Lecture The evolving role of immunotherapy in lymphomas Robert Chen
Hodgkin Lymphoma and T-cell LymphomaChairmen: Paolo Corradini, Umberto Ricardi
11.30-11.50 Histopathological and biological characterization of high risk Hodgkin Lymphoma Harald Stein
11.50-12.10 How I treat high risk Hodgkin Lymphoma Pier Luigi Zinzani
12.10-12.30 Histopathology and molecular biology of T-cell Lymphoma Stefano A. Pileri
12.30-12.50 How I treat high risk T-cell Lymphomas Francesco A. D’Amore
12.50-13.10 Panel Discussion
13.10-14.10 Lunch
Mantle Cell LymphomaChairmen: Michele Spina, Carlo Visco 14.10-14.30 Biological identification of high risk Mantle Cell Lymphoma Simone Ferrero
14.30-14.50 How I treat high risk Mantle Cell Lymphoma in first line Olivier Hermine
14.50-15.10 How I treat relapsed/refractory Mantle Cell Lymphoma Georg Hess
15.10-15.20 Panel Discussion
4 5
THURSDAY SEPTEMBER 13, 2018 Unmet challenges in high risk hematological malignancies:
from benchside to clinical practice
Chronic Lymphocitic Leukemia and Indolent LymphomaChairmen: Marco Ladetto, Giuseppe Rossi
17.20-17.40 Biology of high risk CLL Gianluca Gaidano
17.40-18.00 How I treat of high risk CLL Francesc Bosch
18.00-18.20 Biological definition of high risk FL Alberto Zamò
18.20-18.40 How I treat high risk FL Wolfang Hiddemann
18.40-19.00 Panel Discussion
High Risk Aggressive LymphomasChairmen: Maurizio Martelli, Umberto Vitolo 15.20-15.40 Biological identification of high risk DLBCL Georg Lenz
15.40-16.00 How I treat high risk DLBCL in first line Grzegorz Nowakowski
16.00-16.20 How I treat DLBCL in relapse Annalisa Chiappella
16.20-16.40 How I treat high risk extranodal DLBCL Andres J.M. Ferreri
16.40-17.00 Panel Discussion
17.00-17.20 Coffee Break
6
Multiple Myeloma and Waldenström MacroglobulinemiaChairmen: Mario Boccadoro, Massimo Massaia
8.30-8.50 Biology of high risk Multiple Myeloma Avet Loiseau
8.50-9.10 How I treat elderly high risk Multiple Myeloma Alessandra Larocca
9.10-9.30 How I treat high risk Waldenström Macroglobulinemia Christian Buske
9.30-9.50 Panel Discussion
9.50-10.20 Lecture CAR-T cell therapy pros and contras Stephen Schuster
10.20-10.40 Coffee Break
FRIDAY SEPTEMBER 14, 2018
7
Myeloprolipherative Disorders Chairmen: Angelo M. Carella, Giovanna Rege Cambrin
10.40-11.00 Biology of high risk myeloprolipherative disorders Ayalew Tefferi
11.00-11.20 How I treat high risk CML Patrizia Pregno
11.20-11.40 How I treat high risk Myeloprolipherative neoplasm Francesco Passamonti
11.40-12.00 Panel Discussion
12.00-13.00 Lunch
Unmet challenges in high risk hematological malignancies:
from benchside to clinical practice
FRIDAY SEPTEMBER 14,2018
Acute Lymphoblastic LeukemiaChairmen: Robin Foà, Alessandro Rambaldi
13.00-13.20 Biology of high risk ALL Jan Trka
13.20-13.40 How I treat high risk ALL in first line Renato Bassan
13.40-14.00 How I treat relapsed/refractory ALL Felicetto Ferrara
14.00-14.20 Panel Discussion
8 9
Unmet challenges in high risk hematological malignancies:
from benchside to clinical practice
Acute Lymphoblastic Leukemia and Myelodisplastic SyndromeChairmen: Fabrizio Pane, Emanuele Angelucci
14.20-14.40 Genomic identification of high risk AML Brunangelo Falini
14.40-15.00 How I treat high risk MDS Matteo G. Della Porta
15.00-15.20 How I treat high risk AML Sergio Amadori
15.20-15.40 Panel Discussion
15.40-16.00 Closing remarks Marco Ladetto, Umberto Vitolo
ORGANIZING SECRETARIAT Studio E.R. Congressi Via Marconi, 36 - 40122 Bologna, Italy Phone +39 051 4210559 - Fax +39 051 4210174 E-mail: [email protected]
www.ercongressi.it stru
chel
.com
MEETING VENUE Torino Incontra Centro Congressi Via Nino Costa, 8 - 10123 Turin, Italy
Tel. +39 011 5576800 / +39 011 5576892
SCIENTIFIC BOARD Marco Ladetto MD Head of Hematology Division SS Antonio e Biagio and Cesare Arrigo Hospital Via Venezia, 16 - 15121 Alessandria, Italy
Umberto Vitolo MD Head of Hematology Division Department of Oncology University-Hospital Città della Salute e della Scienza di Torino C.so Bramante, 88/90 - 10126 Turin, Italy
SCIENTIFIC COMMITTEEProf. Mario Boccadoro (Turin)Prof. Gianluca Gaidano (Novara)Prof. Massimo Massaia (Cuneo)
Prof. Giuseppe Saglio (Turin)
REGISTRATIONRegistrations can be requested submitting the online registration form available on the website: www.ercongressi.it
ITALIAN CME CREDITSAn Italian CME application has been submitted as follows: • Provider Studio ER Congressi SRL: ID 828-218390. • No. 7 CME credits for Physicians (Haematology, Oncology, Internal Medicine) and Biologists.• Educational objective: “linee guida-protocolli-procedure”.
OFFICIAL LANGUAGEEnglish
BADGEAll registered participants and speakers will be given a badge which they must wear to be admitted to the scientific sessions.
ATTENDANCE CERTIFICATEA certificate will be given to all participants at the end of the meeting.
CHANGESParts of the program may be changed without notice.
GENERAL INFORMATION